Mark Bertolini Leads Oscar Health’s Strategic Shift into the Employer Market
Mark Bertolini, who took over as CEO of Oscar Health a year ago, has steered the company toward profitability and is now focusing on expanding into the employer market as…
Mark Bertolini, who took over as CEO of Oscar Health a year ago, has steered the company toward profitability and is now focusing on expanding into the employer market as…
Biogen reported strong second-quarter earnings and revenue on Thursday, surpassing market expectations and prompting the company to raise its full-year guidance. The biotech firm's cost-cutting measures have begun to show…
On Friday, Bristol Myers Squibb announced second-quarter earnings and revenue that exceeded expectations, subsequently raising its full-year guidance as the company implements significant cost-reduction strategies. The pharmaceutical leader adjusted its…
Bhava is a Bevacizumab biosimilar and it will be marketed in strengths of 100 mg/4ml and 400 mg/16ml. Zydus Life said in a statement that Bhava is used for the…
Paradromics, a brain implant company made some announcements regarding the first in-human trial which is to be conducted next year and the company also reiterated that it is taking the…
Several new medicines, including two cancer treatments, have been approved for routine use on the NHS in Scotland. On Monday, the Scottish Medicines Consortium (SMC) announced the approval of Opdualag,…
The surge is considered to be caused by diminishing immunity and a novel set of Covid variants collectively known as FLiRT. Experts warn that COVID-19 "hasn't gone away" following an…
Researchers at the University of Galway developed digital babies to better understand infants' health throughout their vital first 180 days of life. The researchers developed 360 powerful computer models to…
Scientists have reported that a game-changing cancer test could provide a precise diagnosis of brain cancer in children in just ten minutes. The most common brain tumour in children, medulloblastoma,…
A leading supplier of digital pathology solutions, Indica Labs, has declared that its corporate digital pathology platform, HALO AP Dx, for primary diagnosis, has been cleared by the FDA. The…